(Q30810943)

English

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 June 2017

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes (English)

1 reference

Europe PubMed Central

26 June 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

cardiovascular disease in women

0 references

Elizabeth Barrett-Connor

1

object named as

Elizabeth Barrett-Connor

0 references

Kristine Ensrud

2

object named as

Kristine E Ensrud

1 reference

Europe PubMed Central

26 June 2017

Andreas Sashegyi

5

object named as

Andreas Sashegyi

1 reference

Europe PubMed Central

26 June 2017

author name string

Kristine Harper

3

1 reference

Europe PubMed Central

26 June 2017

Timothy M Mason

4

1 reference

Europe PubMed Central

26 June 2017

Kathryn A Krueger

6

1 reference

Europe PubMed Central

26 June 2017

Pamela W Anderson

7

1 reference

Europe PubMed Central

26 June 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

26 June 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

26 June 2017

25

1 reference

Europe PubMed Central

26 June 2017

3

1 reference

Europe PubMed Central

26 June 2017

919-930

1 reference

Europe PubMed Central

26 June 2017

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of hormone replacement therapy on plasma lipids in type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycated Haemoglobin: An Assessment of High Capacity Liquid Chromatographic and Immunoassay Methods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of raloxifene on glyco-insulinemic homeostasis in healthy postmenopausal women: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes and atherosclerosis--a lipoprotein perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypertriglyceridemia as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and methods of the Raloxifene Use for The Heart (RUTH) study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980114-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80114-5

1 reference

Europe PubMed Central

26 June 2017

1 reference

Europe PubMed Central

26 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30810943&oldid=1743624081"